NIH workshop tries to create consensus on HRT use.
Randal
Judith
J
D000367:Age Factors; D001943:Breast Neoplasms / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D015975:Consensus Development Conferences, NIH as Topic; D003327:Coronary Disease / Q000517:prevention & control; D004338:Drug Combinations; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D004966:Estrogens, Conjugated (USP); C466383:Prempro; D017258:Medroxyprogesterone Acetate